Biomerica Stock Future Price Prediction

BMRA -  USA Stock  

USD 3.75  0.12  3.31%

Biomerica stock price prediction is an act of determining the future value of Biomerica shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Biomerica's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Biomerica and does not consider all of the tangible or intangible factors available from Biomerica's fundamental data. We analyze noise-free headlines and recent hype associated with Biomerica, which may create opportunities for some arbitrage if properly timed.
Continue to Biomerica Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Biomerica based on different types of headlines from major news networks to social media. The Biomerica stock price prediction module provides an analysis of price elasticity to changes in media outlook on Biomerica over a specific investment horizon. Using Biomerica hype-based prediction, you can estimate the value of Biomerica from the perspective of Biomerica response to recently generated media hype and the effects of current headlines on its competitors.
Biomerica Asset Turnover is projected to slightly decrease based on the last few years of reporting. The past year's Asset Turnover was at 0.61. The current year Gross Margin is expected to grow to 0.26, whereas Book Value per Share is forecasted to decline to 1.27.
This module is based on analyzing investor sentiment around taking a position in Biomerica. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Biomerica to buy its stock at a price that has no basis in reality. In that case, they are not buying Biomerica because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Biomerica after-hype prediction price

    
  $ 3.73  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biomerica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biomerica in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
1.345.449.54
Details
Naive
Forecast
LowNext ValueHigh
0.073.727.82
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.5010.8313.00
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-0.53-0.5-0.45
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biomerica. Your research has to be compared to or analyzed against Biomerica's peers to derive any actionable benefits. When done correctly, Biomerica's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biomerica.

Biomerica After-Hype Price Prediction Density Analysis

As far as predicting the price of Biomerica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biomerica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Biomerica, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Biomerica Estimiated After-Hype Price Volatility

In the context of predicting Biomerica's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biomerica's historical news coverage. Biomerica's after-hype downside and upside margins for the prediction period are 0.19 and 7.83, respectively. We have considered Biomerica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.75
2nd of August 2021
3.73
After-hype Price
7.83
Upside
Biomerica is moderately volatile asset. Analysis and calculation of next after-hype price of Biomerica is based on 3 months time horizon.

Biomerica Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Biomerica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biomerica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biomerica, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.18  4.10  0.02   0.09  9 Events / Month5 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.753.730.53 
4,556  

Biomerica Hype Timeline

Biomerica is currently traded for 3.75. The entity has historical hype elasticity of -0.02 and average elasticity to hype of competition of 0.09. Biomerica is projected to decline in value after the next headline with price expected to drop to 3.73. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.53% whereas the daily expected return is currently at -0.18%. The volatility of related hype on Biomerica is about 813.9% with expected price after next announcement by competition of 3.84. About 17.0% of the company shares are held by company insiders. The book value of Biomerica was currently reported as 0.86. The company recorded a loss per share of 0.47. Biomerica had not issued any dividends in recent years. The entity had 1:2 split on the 7th of April 2016. Given the investment horizon of 90 days the next projectedpress releasewill be in about 9 days.
Continue to Biomerica Basic Forecasting Models to cross-verify your projections.

Biomerica Related Hype Analysis

Having access to credible news sources related to Biomerica's direct competition is more important than ever and may enhance your ability to predict Biomerica's future price movements. Getting to know how Biomerica rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biomerica may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Agilent Technologies 0.89 10 per month 0.59  0.17  1.49 (1.35)  4.54 
Global Cord Blood 0.08 4 per month 2.19  0.0082  4.23 (3.53)  13.89 
Guardant Health 1.44 6 per month 0.00 (0.22)  3.42 (5.27)  11.66 
Laboratory Corp(1.81) 3 per month 0.99  0.13  1.98 (1.52)  6.25 
Dermtech 3.83 10 per month 0.00 (0.07)  6.59 (7.58)  24.42 
Emmaus Life Sciences 0.16 8 per month 3.07  0.06  8.03 (6.92)  32.89 
Exact Sciences Cor(0.49) 9 per month 0.00 (0.12)  4.53 (4.63)  13.01 
Fluidigm Corp(0.07) 8 per month 3.36  0.15  6.23 (5.65)  26.70 

Biomerica Additional Predictive Modules

Most predictive techniques to examine Biomerica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biomerica using various technical indicators. When you analyze Biomerica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biomerica Predictive Indicators

The successful prediction of Biomerica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biomerica, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biomerica based on analysis of Biomerica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biomerica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biomerica's related companies.
 2018 2019 2020 2021 (projected)
Book Value per Share0.431.41.611.27
Asset Turnover1.010.680.610.72

Story Coverage note for Biomerica

The number of cover stories for Biomerica depends on current market conditions and Biomerica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biomerica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biomerica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Biomerica Short Properties

Biomerica's future price predictability will typically decrease when Biomerica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biomerica often depends not only on the future outlook of the potential Biomerica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biomerica's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out8.30%
Short Percent Of Float10.04%
Float Shares10.18M
Shares Short Prior Month1.03M
Average Daily Volume Last 10 Day346.17k
Average Daily Volume In Three Month314.76k
Date Short Interest15th of April 2021
Continue to Biomerica Basic Forecasting Models to cross-verify your projections. Note that the Biomerica information on this page should be used as a complementary analysis to other Biomerica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Biomerica Stock analysis

When running Biomerica price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine Biomerica value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.